Announcing a Clinical Trial That Lowers the Cost of IVF

[April 24, 2015: This clinical trial is no longer open.]

We are delighted that InVia Fertility Specialists has been chosen to participate in an upcoming clinical trial that lowers the cost of IVF for patients.

The study is: Finox 3002-A Phase 3 investigator and assessor-blinded 1:1 randomized, parallel-group to compare efficacy and safety of two r-h FSH formulations in normal ovulatory women 35-42 years of age undergoing In Vitro Fertilization (IVF).

You may qualify pending:

INCLUSION CRITERIA:

• Indications Of Controlled Ovarian Stimulation And IVF/ICSI
• Regular Menstrual Cycles (25-35 Days)
• History Of Maximum

EXCLUSION CRITERIA:

• History Of PCOS
• History Of >2 Unsuccessful ART Retrieval Cycles
• History Of Fibroids >5 Cm
• History Of Recurrent Spontaneous Abortions (Greater Than 3)
• History Of Poor Response
• Severe Endometriosis